Form 8-K - Current report:
SEC Accession No. 0001558370-24-014186
Filing Date
2024-11-04
Accepted
2024-11-04 09:11:32
Documents
15
Period of Report
2024-11-04
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K fbio-20241104x8k.htm   iXBRL 8-K 42000
  Complete submission text file 0001558370-24-014186.txt   227350

Data Files

Seq Description Document Type Size
2 EX-101.SCH fbio-20241104.xsd EX-101.SCH 4833
3 EX-101.DEF fbio-20241104_def.xml EX-101.DEF 14891
4 EX-101.LAB fbio-20241104_lab.xml EX-101.LAB 13025
5 EX-101.PRE fbio-20241104_pre.xml EX-101.PRE 15198
17 EXTRACTED XBRL INSTANCE DOCUMENT fbio-20241104x8k_htm.xml XML 7218
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35366 | Film No.: 241421034
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)